Cardiometabolic outcome trials Prospective study of older adults (mean age 68 years) using liraglutide 3 mg once daily for 24 weeks found improved body composition with reductions in central fat mass, and preserved muscular performance [86, 87], explained by increased myogenesis in myoblasts [88], and the recruitment of skeletal muscle microvasculature [89]
Moreover, 4-hydroxy-2-nonenal (HNE), a major ,-unsaturated aldehyde product of n-6 fatty acid oxidation, is involved in metabolic and neurodegenerative diseases, inflammatory diseases, and cancer (80)
Additional Trial Success A third phase 3 study, CORALreef AddOn, showed enlicitide outperformed non-statin cholesterol drugs ezetimibe and bempedoic acid in LDL-C reduction at Week 8
Formulated with high-purity Glutathionea powerful antioxidant known for its exceptional skin-brightening propertiesthis sheet mask works tirelessly to diminish the appearance of hyperpigmentation, dark spots, and uneven skin tone
For most patients, metformin plus tirzepatide is now preferred over metformin plus insulin, unless insulin is specifically needed (very high HbA1c, type 1 diabetes features, etc.)
